메뉴 건너뛰기
Inflammatory Bowel Diseases
Volumn 13, Issue 10, 2007, Pages 1315-1317
Restoration of soluble CD146 in patients with Crohn's disease treated with the TNF-α antagonist infliximab [4]
Author keywords

[No Author keywords available]
Indexed keywords

CD146 ANTIGEN; GLYCOPROTEIN; INFLIXIMAB; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;
EID: 35348958497     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.20166     Document Type: Letter
Times cited : (8)
References (8)
  • 1
    • 0035895081 scopus 로고    scopus 로고
    • Identification of CD146 as a component of the endothelial junction involved in the control of cell-cell cohesion
    • Bardin N, Anfosso F, Masse JM, et al. Identification of CD146 as a component of the endothelial junction involved in the control of cell-cell cohesion. Blood. 2001;98:3677-3684.
    • (2001) Blood , vol.98 , pp. 3677-3684
    • Bardin, N.1    Anfosso, F.2    Masse, J.M.3
  • 2
    • 0038305607 scopus 로고    scopus 로고
    • A novel anti-CD146 monoclonal antibody, AA98, inhibits angiogenesis and tumor growth
    • Yan X, Lin Y, Yang D, et al. A novel anti-CD146 monoclonal antibody, AA98, inhibits angiogenesis and tumor growth. Blood. 2003;102:184-191.
    • (2003) Blood , vol.102 , pp. 184-191
    • Yan, X.1    Lin, Y.2    Yang, D.3
  • 3
    • 29744445888 scopus 로고    scopus 로고
    • Increased expression of CD146, a new marker of the endothelial junction in active inflammatory bowel disease
    • Bardin N, Reumaux D, Geboes K, et al. Increased expression of CD146, a new marker of the endothelial junction in active inflammatory bowel disease. Inflamm Bowel Dis. 2006;12:16-21.
    • (2006) Inflamm Bowel Dis , vol.12 , pp. 16-21
    • Bardin, N.1    Reumaux, D.2    Geboes, K.3
  • 4
    • 0033677357 scopus 로고    scopus 로고
    • Doppler US in patients with Crohn's disease: Vessel density in the diseased bowel reflects disease activity
    • Spalinger J, Patriquin H, Miron MC, et al. Doppler US in patients with Crohn's disease: vessel density in the diseased bowel reflects disease activity. Radiology. 2000;217:787-791.
    • (2000) Radiology , vol.217 , pp. 787-791
    • Spalinger, J.1    Patriquin, H.2    Miron, M.C.3
  • 5
    • 0030954732 scopus 로고    scopus 로고
    • A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group
    • Targan SR, Hanauer SB, van Deventer SJ, et al. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group. N Engl J Med. 1997;337:1029-1035.
    • (1997) N Engl J Med , vol.337 , pp. 1029-1035
    • Targan, S.R.1    Hanauer, S.B.2    van Deventer, S.J.3
  • 6
    • 0037018761 scopus 로고    scopus 로고
    • ACCENT I Study Group. Maintenance infliximab for Crohn's disease: The ACCENT I randomised trial
    • Hanauer SB, Feagan BG, Lichtenstein GR, et al. ACCENT I Study Group. Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial. Lancet. 2002;359:1541-1549.
    • (2002) Lancet , vol.359 , pp. 1541-1549
    • Hanauer, S.B.1    Feagan, B.G.2    Lichtenstein, G.R.3
  • 7
    • 2342491491 scopus 로고    scopus 로고
    • Anti-angiogenic effects of anti-tumor necrosis factor alpha therapy with infliximab in psoriatic arthritis
    • Canete JD, Pablos JL, Sanmarti R, et al. Anti-angiogenic effects of anti-tumor necrosis factor alpha therapy with infliximab in psoriatic arthritis. Arthritis Rheum. 2004;50:1636-1641.
    • (2004) Arthritis Rheum , vol.50 , pp. 1636-1641
    • Canete, J.D.1    Pablos, J.L.2    Sanmarti, R.3
  • 8
    • 33744510694 scopus 로고    scopus 로고
    • Angiogenesis as a novel component of inflammatory bowel disease pathogenesis
    • Danese S, Sans M, de la Mott C, et al. Angiogenesis as a novel component of inflammatory bowel disease pathogenesis. Gastroenterology. 2006;130:2060-2073.
    • (2006) Gastroenterology , vol.130 , pp. 2060-2073
    • Danese, S.1    Sans, M.2    de la Mott, C.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.